查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944483

全球治疗性神经毒素市场：产业分析、市场规模、份额及2025-2032年预测（按类型、应用、最终用户、国家和地区划分）

Therapeutic Neurotoxin Market, By Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年治疗性神经毒素市场规模价值为62.3465亿美元，从2025年到2032年将以8.53%的复合年增长率成长。

治疗性神经毒素是生物来源的蛋白质毒素，其中最常见的是纯化的肉毒桿菌。它们以受控的医疗剂量用于治疗多种神经系统、肌肉系统和腺体系统的疾病。临床使用的神经毒素透过抑制神经肌肉接头处乙酰胆碱的释放发挥作用，从而降低肌肉活动并导致神经活动异常。治疗性神经毒素的作用机制使其可用于治疗慢性偏头痛、痉挛、颈部肌张力不全症、膀胱过动症、多汗症和某些运动障碍，以及用于美容目的。经过适当训练的医护人员可以使用治疗性神经毒素产生标靶作用，且此作用可持续直至逆转。这使得这些神经毒素成为有效的治疗方法，能够带来医疗益处并改善生活品质。

治疗性神经毒素的市场动态

对微创美容手术的需求日益增长

由于微创美容疗程的趋势日益增长，治疗性神经毒素市场正在蓬勃发展。患者越来越倾向于选择非手术治疗，这些治疗疗程短、无需恢復期、不适感小、健康风险低，却能带来显着的美容效果。治疗性神经毒素的组合疗法，能够快速有效地减少脸部皱纹和细纹，使其成为吸引各类客户的理想选择。随着人们对脸部美的关注度不断提高，社群媒体平台不断推崇新的美学标准，以及美容疗程越来越被老年人所接受，这一趋势仍在持续。随着注射技术和产品配方不断提升安全性和疗效标准，诊所和医疗美容中心能够提供重复治疗，加速市场成长。安全性和疗效的双重进步，促使更多诊所和医疗美容中心采用这些产品，进一步巩固了市场地位。

治疗性神经毒素市场：細項分析

按类型

截至2024年，A型肉毒桿菌毒素占据市场主导地位。其经临床验证的疗效和安全性，以及其核准的多种医疗和美容用途，构成了市场的基础。 A型肉毒桿菌毒素的医疗用途包括治疗慢性偏头痛、痉挛和颈肌肌张力不全症、膀胱过动症和多汗症，同时在非手术美容治疗中也广受欢迎。其广泛的监管核准历史，以及完善的临床资料库，赢得了医生的高度信赖和患者的广泛接受，从而推动了治疗的持续进行和稳定的产品需求。

治疗性神经毒素市场—区域分析

北美引领着整个产业。这一市场扩张主要受三大区域因素驱动：美国及其周边市场凭藉先进的医疗设施和高所得水平，持续将神经毒素产品用于治疗和美容用途。微创疗法在治疗慢性偏头痛、痉挛、膀胱过动症和多汗症方面的日益普及，使得医疗专业人员能够将这些疗法应用于非美容领域，从而拓展收入来源。监管核准与新型配方和适应症的产品开发之间的协同作用，有望在未来创造新的治疗选择，并进一步提高医疗专业人员和患者的接受度。

目录

第一章 治疗性神经毒素市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

3. 治疗性神经毒素的关键市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

4. 治疗性神经毒素市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

5. 治疗性神经毒素市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：治疗性神经毒素市场概况

  • 治疗性神经毒素市场占有率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 治疗性神经毒素市场（按类型划分）

  • 概述
    • 细分市场占有率分析：按类型
    • A型肉毒桿菌毒素
    • B型肉毒桿菌

8. 按应用分類的治疗性神经毒素市场

  • 概述
    • 细分市场占有率分析：按应用
    • 慢性偏头痛
    • 眼睑痉挛
    • 膀胱过动症
    • 痉挛
    • 颈部肌肌张力不全症
    • 其他的

9. 按最终用户分類的治疗性神经毒素市场

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 专科诊所
    • 其他的

10. 各地区治疗性神经毒素市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十一章 主要供应商分析—治疗性神经毒素产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • AbbVie Inc.
    • Croma-Pharma GmbH
    • Ipsen SA
    • Daewoong Pharmaceutical Co. Ltd.
    • Supernus Pharmaceuticals
    • Merz Pharma GmbH &Co KGaA
    • Hugel Inc.
    • Galderma Inc.
    • Medytox Inc.
    • Evolus Inc.
    • Revance Therapeutics Inc.

第十二章：分析师视角360度分析

简介目录
Product Code: ANV6036

The Therapeutic Neurotoxin Market size was valued at US$6,234.65 Million in 2024, expanding at a CAGR of 8.53% from 2025 to 2032.

Therapeutic neurotoxins are biologically derived protein toxins most commonly purified forms of botulinum toxin that are used in controlled, medical doses to treat a wide range of neurological, muscular, and glandular disorders. The neurotoxins used in clinical practice function by stopping acetylcholine release at neuromuscular junctions which leads to decreased muscle activation and abnormal nerve activity. The mechanism of action in therapeutic neurotoxins enables their use for treating chronic migraine spasticity cervical dystonia overactive bladder, hyperhidrosis and specific movement disorders together with their popular cosmetic uses. Healthcare professionals who receive appropriate training can use therapeutic neurotoxins to produce targeted effects that last until the effects need to be reversed making these neurotoxins an efficient treatment method that provides medical advantages and enhances life quality.

Therapeutic Neurotoxin Market- Market Dynamics

Rising demand for minimally invasive aesthetic procedures

The therapeutic neurotoxin market experiences growth because more people want to undergo minimally invasive aesthetic treatments. Patients increasingly prefer non-surgical treatments which provide visible aesthetic improvements through short procedures that require no recovery time, minimal discomfort and low chances of danger to their health. The combination of therapeutic neurotoxins which deliver fast outpatient procedures that reduce facial wrinkles and fine lines has created a treatment option which appeals to diverse customers. The trend continues because people become more aware of facial aesthetics and social media platforms promote aesthetic standards and both younger and older generations show greater acceptance of cosmetic procedures. The market growth accelerates because injection techniques and product formulations have reached new safety and treatment outcome standards which encourage clinics and medical spas to offer repeat treatments. The dual advance of safety and treatment outcomes strengthens the market because more clinics and medical spas adopt these products.

Therapeutic Neurotoxin Market- Segmentation Analysis:

By Type

In 2024, the botulinum toxin type A dominated the market. The market functions mainly because of its proven clinical effectiveness and safety record, as well as its multiple approved medical and cosmetic uses. The medical use of botulinum toxin type A extends to chronic migraine, spasticity and cervical dystonia, overactive bladder, hyperhidrosis, and its high popularity in non-surgical cosmetic treatments. The combination of its extensive regulatory approval history and its comprehensive clinical database has created high trust among doctors and strong acceptance among patients, resulting in ongoing treatment and steady product demand.

Therapeutic Neurotoxin Market- Geographical Insights

North America leads the industry. The expansion of this market relies on three primary regional factors. The United States, together with its nearby markets, uses advanced medical facilities and high-income levels to sustain both therapeutic and cosmetic usage of neurotoxin products. The growing popularity of minimally invasive treatments for chronic migraine and spasticity, overactive bladder, and hyperhidrosis conditions has permitted medical professionals to use these procedures for more than just cosmetic reasons, which has resulted in a larger income stream. The combination of regulatory approvals and product development for new formulations and indications has created additional treatment options, which medical professionals and patients will increasingly adopt.

Therapeutic Neurotoxin Market- Competitive Landscape:

The therapeutic neurotoxin market functions as an oligopoly while it continues to experience market changes because three major established companies control worldwide sales but new competitors, local producers and biosimilar products now enter the market to create price competition and develop new medical applications. The global market leaders AbbVie/Allergan (BOTOX(R)), Ipsen (DYSPORT(R)), and Merz (XEOMIN(R)) together control most branded sales because their products have extensive clinical backgrounds and multiple approved uses and their brand names are well-known to doctors and patients.

Recent Developments:

In September 2025, Allergan Aesthetics, an AbbVie company announced a new chapter for BOTOX(R) Cosmetic with the debut of "The One & Only" campaign, a national, multichannel marketing initiative that champions self-expression and individuality. BOTOX(R) Cosmetic became the first and only brand to achieve this milestone because it now holds the status of the top-selling neurotoxin worldwide, which has received FDA approval for more aesthetic treatment areas than any other product in its category.

In April 2025, AbbVie has filed a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for their product trenibotulinumtoxinE (TrenibotE) which treats moderate to severe glabellar lines.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC NEUROTOXIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Croma-Pharma GmbH
  • Ipsen SA
  • Daewoong Pharmaceutical Co. Ltd.
  • Supernus Pharmaceuticals
  • Merz Pharma GmbH & Co KGaA
  • Hugel Inc.
  • Galderma Inc.
  • Medytox Inc.
  • Evolus Inc.
  • Revance Therapeutics Inc.

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Chronic Migraine
  • Blepharospasm
  • Overactive Bladder
  • Spasticity
  • Cervical Dystonia
  • Others

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Others

GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Therapeutic Neurotoxin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Therapeutic Neurotoxin Market Snippet by Type
    • 2.1.2. Therapeutic Neurotoxin Market Snippet by Application
    • 2.1.3. Therapeutic Neurotoxin Market Snippet by End-User
    • 2.1.4. Therapeutic Neurotoxin Market Snippet by Country
    • 2.1.5. Therapeutic Neurotoxin Market Snippet by Region
  • 2.2. Competitive Insights

3. Therapeutic Neurotoxin Key Market Trends

  • 3.1. Therapeutic Neurotoxin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Therapeutic Neurotoxin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Therapeutic Neurotoxin Market Opportunities
  • 3.4. Therapeutic Neurotoxin Market Future Trends

4. Therapeutic Neurotoxin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Therapeutic Neurotoxin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Therapeutic Neurotoxin Market Landscape

  • 6.1. Therapeutic Neurotoxin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Therapeutic Neurotoxin Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Botulinum Toxin Type A
    • 7.1.3. Botulinum Toxin Type B

8. Therapeutic Neurotoxin Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Chronic Migraine
    • 8.1.3. Blepharospasm
    • 8.1.4. Overactive Bladder
    • 8.1.5. Spasticity
    • 8.1.6. Cervical Dystonia
    • 8.1.7. Others

9. Therapeutic Neurotoxin Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024&2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Others

10. Therapeutic Neurotoxin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Therapeutic Neurotoxin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Therapeutic Neurotoxin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Therapeutic Neurotoxin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Therapeutic Neurotoxin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Therapeutic Neurotoxin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Therapeutic Neurotoxin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Croma-Pharma GmbH
    • 11.2.3. Ipsen SA
    • 11.2.4. Daewoong Pharmaceutical Co. Ltd.
    • 11.2.5. Supernus Pharmaceuticals
    • 11.2.6. Merz Pharma GmbH & Co KGaA
    • 11.2.7. Hugel Inc.
    • 11.2.8. Galderma Inc.
    • 11.2.9. Medytox Inc.
    • 11.2.10. Evolus Inc.
    • 11.2.11. Revance Therapeutics Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us